Skip to main content

Cannabis seedlings at Tilray a medical marijuana grow-op in Nanaimo, B.C.

John Lehmann/The Globe and Mail

Health Canada has ordered the country's medical marijuana growers to stop advertising their products with treatment claims and promotional images.

The federal department issued letters this week to licensed pot producers, warning them to overhaul their advertising and marketing content on websites and social media by Jan. 12.

Health Canada says failure to comply could lead to suspension or revocation of the company's commercial licence.

Story continues below advertisement

Individualized letters were sent to 20 of Canada's 22 licensed growers, spelling out what each company needs to change to comply with rules governing advertising of medical cannabis.

Those rules prohibit companies from advertising "any food, drug, cosmetic or device to the general public as a treatment, preventative or cure for any of the diseases, disorders or abnormal physical states."

Health Canada says producers should provide limited information to prospective clients, including the brand name, proper or common name of the strain, price per gram, cannabinoid content, and the company's contact details.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter